Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems
Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems
Sayona Mining (ASX:SYA) announced that their preliminary technical study at their NAL lithium carbonate plant study produces an NPV of A$3.2bn. Sayona's Managing Director, Brett Lynch commented: "Significantly, NAL is set to become the only lithium operation with a concentrator and carbonate plant all on the same site in North America. Shares are trading flat at 18 cents.
Sayona Mining（澳大利亚证券交易所股票代码：SYA）宣布，他们在NAL碳酸锂工厂研究中进行的初步技术研究产生了32亿澳元的净现值。Sayona董事总经理Brett Lynch评论说：“值得注意的是，NAL将成为北美唯一一家在同一地点拥有浓缩器和碳酸盐工厂的锂企业。股价持平至18美分。
Tamboran Resources (ASX:TBN) has entered into a Framework Agreement with the Clean Energy Fuels Australia (CEFA) to obtain exclusivity over gas compression and liquefaction facilities from the Beetaloo Basin. MD and CEO, Joel Riddle, said: "This is the first step in fulfilling our promise to provide these remote communities with alternative affordable and cleaner fuel." Shares are trading flat at 21 cents.
坦博兰资源（澳大利亚证券交易所股票代码：TBN）已与澳大利亚清洁能源燃料协会（CEFA）签订框架协议，以获得Beetaloo盆地天然气压缩和液化设施的独家经营权。总经理兼首席执行官乔尔·里德尔说：“这是兑现我们为这些偏远社区提供负担得起和更清洁的替代燃料的承诺的第一步。”股价持平至21美分。
Imagion Biosystems (ASX:IBX) is set to complete the MagSense HER2 Phase 1 Study. Bob Proulx, Imagion's CEO, commented, "this now provides strong footing for us to move ahead with our HER2 breast cancer program." Shares are trading 29.17 per cent higher at 1.55 cents.
Imagion Biosystems（澳大利亚证券交易所股票代码：IBX）即将完成MagSense HER2第一阶段研究。Imagion首席执行官鲍勃·普罗克斯评论说：“现在，这为我们推进HER2乳腺癌计划提供了坚实的基础。”股价上涨29.17％，至1.55美分。
